Health Care Reform 271 in the last year
The Patient Protection and Affordable Care Act (PPACA) was signed into law on March 23, 2010. That law, along with the Health Care and Education Reconciliation Act of 2010 and related measures is being implemented by Federal agencies to reform certain aspects of the private...
DocumentsWith Comments Requested
Comment PeriodClosing Soon
Agency Information Collection Activities; Proposals, Submissions, and Approvals:
Agriculture and Food Research Initiative Competitive Grants Program:
Animal Welfare
Bulk Manufacturers of Controlled Substances; Applications:
Environmental Assessments; Availability, etc.:
Environmental Impact Statements; Availability, etc.:
Exclusive Licenses:
Exclusive Patent Commercialization Licenses:
Food Additive Petitions; Animal Use:
Food Labeling:
Guidance:
Importers of Controlled Substances; Applications:
Manufacturers of Controlled Substances; Applications:
Medicare Program:
Medicare Programs:
Meetings:
Motor Vehicle Theft Prevention Standard:
Occupational Safety and Health Research and Related Activities:
Petitions for Determination of Nonregulated Status:
Petitions for Rulemaking:
Petitions:
Pipeline Safety:
Possession, Use, and Transfer of Select Agents and Toxins:
Prevailing Rate Systems:
Prospective Grants of Exclusive Patent Commercialization Licenses:
Redesignation of Service Delivery Area:
Requests for Information:
Requests for Nominations:
Requests for Scientific Data and Information:
Risk Assessments:
Rulemaking Petitions:
Safety and Effectiveness of Health Care Antiseptics:
Schedule for Rating Disabilities:
Special Regulations:
Supplemental Nutrition Assistance Program:
Toxicological Profiles:
Treatment Evaluation Documents:
Other
Comment PeriodOpening
Agency Information Collection Activities; Proposals, Submissions, and Approvals:
Bulk Manufacturers of Controlled Substances; Applications:
Environmental Assessments; Availability, etc.:
Exclusive Licenses:
Exclusive Patent Commercialization Licenses:
Importers of Controlled Substances; Applications:
Prospective Grants of Exclusive Patent Commercialization Licenses:
Toxicological Profiles:
Other